CytoDyn Inc (OTCMKT: CYDY) has been under considerable selling pressure since April and nothing seems to be able to stop it. In...
The big news circulating this week was of Atea Pharmaceuticals’ (NASDAQ: AVIR) COVID-19 antiviral clinical trial failure, which instantly plummeted the stock...
Many CytoDyn Inc. (OTCMKTS: CYDY) shareholders have been waiting impatiently for an EUA from the US FDA and a BLA in HIV. ...
Early projections were announced in early January that Kaival Brands (OTCMKTS: KAVL) could do $400-$450M in revenues for 2021, but we feel...
Powerful recommendation from DSMB Imminent on Leronlimab Numbers are not part of any Interim report unless a statistical penalty is taken A...
The manufacturing and distribution of COVID-19 test kits has been a major factor in the market decline costing the US stock market...
Back in August, we published this piece on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS). At the time, the company had just collapsed subsequent...
Today, we will present a new profile, ALR Technologies Inc (OTCMKTS:ALRT), the medical device company, to which FDA has granted clearance for...
For a company that just picked up a major FDA approval, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is trading remarkably flat. Premarket on Thursday,...